Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Lake Street to hold a virtual conference » 08:21
09/17/20
09/17
08:21
09/17/20
08:21
INFU

InfuSystem

$14.36 /

+0.37 (+2.64%)

, CKPT

Checkpoint Therapeutics

$4.25 /

+0.32 (+8.14%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, ICAD

iCAD

$10.42 /

+0.76 (+7.87%)

, STXS

Stereotaxis

$4.09 /

-0.075 (-1.80%)

, OPCH

Option Care Health

$10.96 /

+ (+0.00%)

, VMD

Viemed Healthcare

$9.13 /

+0.955 (+11.69%)

, ATEC

Alphatec

$6.08 /

+ (+0.00%)

4th Annual Best Ideas…

4th Annual Best Ideas Growth (BIG4) Virtual Conference will be held on September 17. Webcast Link

ShowHide Related Items >><<
VMD Viemed Healthcare
$9.13 /

+0.955 (+11.69%)

STXS Stereotaxis
$4.09 /

-0.075 (-1.80%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

OPCH Option Care Health
$10.96 /

+ (+0.00%)

INFU InfuSystem
$14.36 /

+0.37 (+2.64%)

ICAD iCAD
$10.42 /

+0.76 (+7.87%)

CKPT Checkpoint Therapeutics
$4.25 /

+0.32 (+8.14%)

ATEC Alphatec
$6.08 /

+ (+0.00%)

INFU InfuSystem
$14.36 /

+0.37 (+2.64%)

08/31/20
Fly Intel: Top five analyst initiations
08/31/20 Craig-Hallum
InfuSystem initiated with a Buy at Craig-Hallum
06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
CKPT Checkpoint Therapeutics
$4.25 /

+0.32 (+8.14%)

06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
04/13/20 B. Riley FBR
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR
12/27/19 Lake Street
Checkpoint Therapeutics price target lowered to $8 from $12 at Lake Street
10/17/19 Lake Street
Checkpoint Therapeutics shares reflect 'valuation disconnect,' says Lake Street
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

09/15/20 Lake Street
Sanuwave Health initiated with a Buy at Lake Street
ICAD iCAD
$10.42 /

+0.76 (+7.87%)

02/13/20 Craig-Hallum
iCAD price target raised to $15 from $9 at Craig-Hallum
02/05/20 JMP Securities
iCAD initiated with an Outperform at JMP Securities
01/09/20 Lake Street
Lake Street starts 'disruptive' iCAD with Buy rating, $14 price target
12/20/19
iCAD initiated with a Buy at Dougherty
STXS Stereotaxis
$4.09 /

-0.075 (-1.80%)

09/08/20 Northland
Stereotaxis initiated with an Outperform at Northland
06/22/20 Lake Street
Stereotaxis price target raised to $9 from $5 at Lake Street
05/27/20 Lake Street
Stereotaxis financing, addition of Consonance both positive, says Lake Street
04/09/20 Cowen
Stereotaxis initiated with an Outperform at Cowen
OPCH Option Care Health
$10.96 /

+ (+0.00%)

08/05/20 Barrington
Option Care Health price target raised to $19 from $17 at Barrington
07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
VMD Viemed Healthcare
$9.13 /

+0.955 (+11.69%)

04/13/20 Lake Street
CMS decision removes 'big overhang' for Viemed Healthcare, says Lake Street
ATEC Alphatec
$6.08 /

+ (+0.00%)

09/03/20 Cowen
Alphatec initiated with an Outperform at Cowen
06/18/20 Northland
Alphatec initiated with an Outperform at Northland
06/15/20 Canaccord
Alphatec ready for acceleration into thee second half, says Canaccord
05/12/20 Piper Sandler
Alphatec underlying momentum remains strong, says Piper Sandler
VMD Viemed Healthcare
$9.13 /

+0.955 (+11.69%)

STXS Stereotaxis
$4.09 /

-0.075 (-1.80%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

OPCH Option Care Health
$10.96 /

+ (+0.00%)

ICAD iCAD
$10.42 /

+0.76 (+7.87%)

CKPT Checkpoint Therapeutics
$4.25 /

+0.32 (+8.14%)

ATEC Alphatec
$6.08 /

+ (+0.00%)

  • 22
    Jul
  • 20
    Nov
VMD Viemed Healthcare
$9.13 /

+0.955 (+11.69%)

OPCH Option Care Health
$10.96 /

+ (+0.00%)

ICAD iCAD
$10.42 /

+0.76 (+7.87%)

Initiation
Sanuwave Health initiated with a Buy at Lake Street » 09:15
09/15/20
09/15
09:15
09/15/20
09:15
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

Lake Street analyst…

Lake Street analyst Brooks O'Neil initiated coverage of Sanuwave Health with a Buy rating and $0.34 price target. He sees the recent "transformative transactions" to acquire the wound care assets of Celularity and strengthen the company's balance sheet creating an end-to-end product offering to address the advanced wound care market, O'Neil tells investors. He expects the 100-person combined sales organization to leverage its complementary product line-up to drive strong sales and margin expansion, the analyst added.

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Hot Stocks
Sanuwave Health announces reimbursement coverage for BIOVANCE from Centene » 07:16
09/08/20
09/08
07:16
09/08/20
07:16
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, CNC

Centene

$59.70 /

-0.53 (-0.88%)

SANUWAVE Health (SNWV)…

SANUWAVE Health (SNWV) announced that Centene Corporation (CNC) has included SANUWAVE's BIOVANCE in its list of reimbursed skin substitutes for advanced wound healing for the more than 24.5 million lives it covers. BIOVANCE is decellularized, dehydrated human amniotic membrane that is an intact, natural extracellular matrix that acts as a scaffold for restoration of functional tissue. BIOVANCE contains key ECM proteins that allow for the migration of host cells to permeate the graft and promote tissue repair when applied to a wound. BIOVANCE brings the progenerative power of the amnion to tissue regeneration1-6 and provides a foundation for the wound healing process.

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

08/26/20 JPMorgan
Biden policies 'current overhang' on Managed Care sector, says JPMorgan
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
07/29/20 Deutsche Bank
Centene price target raised to $87 from $80 at Deutsche Bank
07/01/20 SVB Leerink
Centene reinstated with an Outperform at SVB Leerink
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

CNC Centene
$59.70 /

-0.53 (-0.88%)

Over a month ago
Conference/Events
Sanuwave Health to hold a conference call » 12:55
08/12/20
08/12
12:55
08/12/20
12:55
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

Management discusses the…

Management discusses the acquisition of the wound care assets of Celularity, consisting of the UltraMIST Ultrasound Healing Therapy assets and partnership rights for Celularity's wound care biologic products on a conference call to be held on August 12 at 1 pm. Webcast Link

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Conference/Events
Sanuwave Health to hold a conference call » 09:37
08/12/20
08/12
09:37
08/12/20
09:37
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

Management discusses the…

Management discusses the acquisition of the wound care assets of Celularity, consisting of the UltraMIST Ultrasound Healing Therapy assets and partnership rights for Celularity's wound care biologic products on a conference call to be held on August 12 at 1 pm. Webcast Link

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Hot Stocks
Sanuwave Health completes acquisition of Celularity wound care assets » 09:14
08/10/20
08/10
09:14
08/10/20
09:14
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

SANUWAVE Health announced…

SANUWAVE Health announced that it has completed the acquisition of the wound care assets of Celularity, consisting of the UltraMIST Ultrasound Healing Therapy assets and partnership rights for Celularity's wound care biologic products. The funding for the acquisition consisted of a mix of funded term debt, a seller note, and equity in the form of a private placement. The private placement generated gross proceeds of approximately $24 million through the issuance of 119,125,000 shares of common stock and accompanying warrants to purchase up to an equal number of shares of common stock at a purchase price of $0.20 per share of common stock and accompanying warrants. The warrants will be exercisable immediately at an exercise price of $0.25 per share and will expire three years after the date of issuance. Over 60% of the private placement was purchased by existing investors and insiders, and the remainder was purchased by certain healthcare focused institutional and accredited investors. The acquisition is expected to be a transformative event for SANUWAVE and represents a strategically and financially compelling growth opportunity for the company. The transaction broadens SANUWAVE's addressable market and combines two highly complementary energy transfer technologies with two biologic skin substitute products to create a platform of scale with an end-to-end product offering in the advanced wound care market. Furthermore, it uniquely positions SANUWAVE to address the entire advanced wound care patient pathway from the initial stages of treatment to closure. The treatment combination of the UltraMIST and the dermaPACE System creates a significant opportunity to demonstrate improved patient outcomes over the current standard of care, initially for diabetic foot ulcers and across all wound indications in the future.

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Over a quarter ago
Conference/Events
Lytham Partners to hold a virtual conference » 04:55
06/25/20
06/25
04:55
06/25/20
04:55
MOGO

Mogo

$0.95 /

-0.0403 (-4.05%)

, SANW

S&W Seed

$2.21 /

-0.04 (-1.78%)

, MNKD

MannKind

$1.86 /

-0.265 (-12.47%)

, CDXC

ChromaDex

$4.46 /

-0.11 (-2.41%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, EAST

Eastside Distilling

$1.52 /

+0.03 (+2.01%)

, AZZ

AZZ Inc.

$32.75 /

-1.44 (-4.21%)

, ICCC

Immucell

$4.43 /

-0.105 (-2.32%)

, INFU

InfuSystem

$11.81 /

-0.5 (-4.06%)

, LIQT

LiqTech

$5.41 /

-0.17 (-3.05%)

, TNP

TEN, Ltd.

$2.02 /

-0.1 (-4.72%)

Investor Growth Virtual…

Investor Growth Virtual Conference will be held on June 24-25 at 9 am. Webcast Link

ShowHide Related Items >><<
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MOGO Mogo
$0.95 /

-0.0403 (-4.05%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

INFU InfuSystem
$11.81 /

-0.5 (-4.06%)

ICCC Immucell
$4.43 /

-0.105 (-2.32%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

MOGO Mogo
$0.95 /

-0.0403 (-4.05%)

06/04/20 B. Riley FBR
Mogo price target lowered to $3 from $4 at B. Riley FBR
03/30/20 B. Riley FBR
Mogo Finance price target lowered to $4 from $7 at B. Riley FBR
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

10/16/19
Fly Intel: Top five analyst initiations
10/16/19
Oppenheimer bullish on ChromaDex, initiates with an Outperform
10/15/19 Oppenheimer
ChromaDex initiated with an Outperform at Oppenheimer
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

ICCC Immucell
$4.43 /

-0.105 (-2.32%)

INFU InfuSystem
$11.81 /

-0.5 (-4.06%)

06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
TEN, Ltd. downgraded to Hold from Buy at Stifel
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

Conference/Events
Lytham Partners to hold a virtual conference » 08:46
06/24/20
06/24
08:46
06/24/20
08:46
MOGO

Mogo

$0.99 /

+0.0046 (+0.46%)

, SANW

S&W Seed

$2.25 /

+ (+0.00%)

, MNKD

MannKind

$2.13 /

-0.08 (-3.63%)

, CDXC

ChromaDex

$4.57 /

-0.02 (-0.44%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, EAST

Eastside Distilling

$1.49 /

+0.04 (+2.76%)

, AZZ

AZZ Inc.

$34.19 /

+0.52 (+1.54%)

, ICCC

Immucell

$4.53 /

+0.03 (+0.67%)

, INFU

InfuSystem

$12.31 /

+0.56 (+4.77%)

, LIQT

LiqTech

$5.58 /

-0.15 (-2.62%)

, TNP

TEN, Ltd.

$2.12 /

-0.095 (-4.29%)

Investor Growth Virtual…

Investor Growth Virtual Conference will be held on June 24-25 at 9 am. Webcast Link

ShowHide Related Items >><<
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.25 /

+ (+0.00%)

MOGO Mogo
$0.99 /

+0.0046 (+0.46%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

INFU InfuSystem
$12.31 /

+0.56 (+4.77%)

ICCC Immucell
$4.53 /

+0.03 (+0.67%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

MOGO Mogo
$0.99 /

+0.0046 (+0.46%)

06/04/20 B. Riley FBR
Mogo price target lowered to $3 from $4 at B. Riley FBR
03/30/20 B. Riley FBR
Mogo Finance price target lowered to $4 from $7 at B. Riley FBR
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
SANW S&W Seed
$2.25 /

+ (+0.00%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

10/16/19
Fly Intel: Top five analyst initiations
10/16/19
Oppenheimer bullish on ChromaDex, initiates with an Outperform
10/15/19 Oppenheimer
ChromaDex initiated with an Outperform at Oppenheimer
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

ICCC Immucell
$4.53 /

+0.03 (+0.67%)

INFU InfuSystem
$12.31 /

+0.56 (+4.77%)

06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
TEN, Ltd. downgraded to Hold from Buy at Stifel
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.25 /

+ (+0.00%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

Hot Stocks
Sanuwave Health enters LOI to acquire Celularity's UltraMist » 07:02
06/10/20
06/10
07:02
06/10/20
07:02
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

SANUWAVE Health announced…

SANUWAVE Health announced that it has entered into an exclusive, non-binding letter of intent to acquire Celularity's UltraMIST Ultrasound Healing Therapy asset as well as exclusive partnership rights for Celularity's wound care biologic products. Celularity is a privately held, clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer, infectious disease, and degenerative disease. SANUWAVE will conduct an investor teleconference at 9:00 a.m. EDT today to discuss how the contemplated acquisition is expected to broaden its wound care portfolio and enhance its financial profile. The transaction is expected to close in July 2020. The funding for the acquisition will consist of a mix of funded term debt and equity. Existing SANUWAVE shareholders, directors and officers have committed over $5 million at $0.25 per share to assist in completing the transaction. SANUWAVE has engaged William Blair for investment banking services to arrange, negotiate and assist in the placement of debt capital for the proposed acquisition. William Blair is in advanced discussions with lenders for the debt capital. The contemplated acquisition is expected to be a transformative event for SANUWAVE and to represent a strategically and financially compelling growth opportunity for the Company. The contemplated transaction would broaden SANUWAVE's addressable market and combines two highly complementary energy transfer technologies with two biologic skin substitute products to create a platform of scale with an end-to-end product offering in the advanced wound care market. Furthermore, it would uniquely position SANUWAVE to address the entire advanced wound care patient pathway from the initial stages of treatment to closure. The treatment combination of UltraMISTand the dermaPACE System would create a significant opportunity to demonstrate improved patient outcomes over the current standard of care, initially for diabetic foot ulcers and across all wound indications in the future.

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Hot Stocks
Sanuwave Health partners with The Mobile Health Company » 09:06
05/18/20
05/18
09:06
05/18/20
09:06
SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

SANUWAVE Health is…

SANUWAVE Health is pleased to announce they will be offering dermaPACE System solutions to treat patients in a home setting. SANUWAVE Health will also have devices placed with THE MOBILE HEALTH COMPANY, a business recently formed by former SANUWAVE President Shri Parikh. Following on the announcement last week of 10 sites using dermaPACE mobile, SANUWAVE Health is pleased to announce they are partnering with former President Shri Parikh, who is launching a mobile solution to wound care and other treatments directly to the patient's home setting. In doing so, Shri will be resigning from SANUWAVE as President, however, he remains an active company advisor.

ShowHide Related Items >><<
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.